Article info
PDFBasic and translational research
Extended report
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis
- Correspondence to Cornelis L Verweij, VU University Medical Center, Inflammatory Disease Profiling, CCA260, PO Box 7057, 1007MB Amsterdam, The Netherlands; c.verweij{at}vumc.nlSV and HGR contributed equally to this work
Citation
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis
Publication history
- Accepted February 1, 2011
- First published March 27, 2011.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions